Dosage Lookup

Peptides

2.5

Moderate

consensus

There is no single 'peptide dose' — it is entirely molecule-specific and set by a prescriber. The shared principle across experts is the smallest effective dose, not the biggest, and only for a peptide with a real indication.

Based on expert consensus data from publicly available videos, not medical advice. Always consult your healthcare provider before starting, stopping, or changing any supplement.

Consensus Protocol

Dosage

  • There is no single 'peptide dose' — it is entirely molecule-specific and set by a prescriber
  • The shared principle across experts is the smallest effective dose, not the biggest, and only for a peptide with a real indication

Form

  • Most therapeutic peptides are injectable (subcutaneous)
  • a few are nasal, oral, or topical
  • The FDA-approved options — PT-141, tesamorelin — come from a licensed pharmacy
  • 'Research-only' vials do not

Timing

  • Cycled, not continuous
  • Several experts caution explicitly against indefinite use of unproven peptides — BPC-157's theoretical tumor-growth risk is the clearest example of why 'forever' is the wrong default

Notes

  • Physician-prescribed and lab-monitored only
  • Avoid gray-market 'research purposes only' vials — they carry LPS/endotoxin contamination, variable purity, and no dosing guarantee
  • Build the foundations first: sleep, resistance training, protein, and proven interventions before any exotic peptide (Hyman, Attia)

Expert Positions

Andrew Huberman
Andrew Huberman
Covers Extensively, Urges Caution
Peter Attia
Peter Attia
Evidence-First Skeptic
Rhonda Patrick
Rhonda Patrick
Cautious — Weak Human Data
Bryan Johnson
Bryan Johnson
No Direct Coverage
Mark Hyman
Mark Hyman
Promising, but Foundations First

What Each Expert Says

Andrew Huberman
Andrew Huberman
Covers Extensively, Urges Caution

Huberman is the panel's anchor on peptides, with two dedicated episodes. In his solo episode he defines the category, lays out the three-tier safety framing, and walks through BPC-157, TB-500/thymosin beta-4, the growth-hormone secretagogues, and melanocortin peptides — repeatedly returning to the need for medical supervision and clean sourcing. His guest episodes add a clinician's enthusiasm (Dr. Craig Koniver) and a careful researcher's caution (Dr. Abud Bakri), including the regulatory reality that the FDA has restricted BPC-157 and CJC-1295.

Unlock Expert Deep Dives

See exactly what each expert recommends — specific dosages, forms, timing protocols, and video citations with timestamps.

Cancel anytime

More on Peptides

Consensus Score Which Form? When to Take Check Your Stack

Common Questions

How much Peptides should you take?

There is no single 'peptide dose' — it is entirely molecule-specific and set by a prescriber. The shared principle across experts is the smallest effective dose, not the biggest, and only for a peptide with a real indication.

What form of Peptides is best?

Most therapeutic peptides are injectable (subcutaneous); a few are nasal, oral, or topical. The FDA-approved options — PT-141, tesamorelin — come from a licensed pharmacy. 'Research-only' vials do not.

When should you take Peptides?

Cycled, not continuous. Several experts caution explicitly against indefinite use of unproven peptides — BPC-157's theoretical tumor-growth risk is the clearest example of why 'forever' is the wrong default.

All dosage lookups